Although we could not detect IL-10R2+ blood cells in PBMCs of these tumour types (data not shown), IL-10R2+ cells might have increased in early tumorigenesis in each cancer, with IL-22 level being high in tumour tissue, and tumour-associated myeloid cells playing an important role. Here, IL22 is linked to cancer.